International Atomic Energy Agency (IAEA) activities on 67Cu, 186Re, 47Sc Theranostic radionuclides and Radiopharmaceuticals: Extraordinary results on the production, Quality Control and preclinical evaluation of selected radionuclides were reported in this project that was finalized in 2020.